Pandemic Flu H5 mRNA Vaccine

Influenza A H5 hemagglutinin mRNA vaccine · Sanofi Pasteur, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pandemic Flu H5 mRNA Vaccine, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older [Phase 1, Phase 2]

See pricing